AI assistant
Sending…
GENTEX CORP — Director's Dealing 2021
Feb 8, 2021
30893_dirs_2021-02-08_b6eeb70d-b1bc-43b1-972d-34b39957022a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2021-02-05
Reporting Person: MULDER JOHN A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-05 | Common Stock | M | 6133.00 | $17.46 | Acquired | 40498.00 | Direct |
| 2021-02-05 | Common Stock | S | 6133.00 | $34.8052 | Disposed | 34365.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-05 | Non-Employee Director Stock Option Grant | $17.46 | M | 6133.00 | Disposed | 2025-05-21 | Common Stock (6133.00) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $34.79 to $34.82. The price reported above reflects the weighted average price.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19